Generation Bio Co.
GBIO
$6.35
$0.223.59%
NASDAQ
06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
---|---|---|---|---|---|
Net Income | -72.42M | -71.93M | -131.67M | -145.47M | -158.43M |
Total Depreciation and Amortization | 4.63M | 4.76M | 4.93M | 5.08M | 5.19M |
Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
Total Other Non-Cash Items | 11.14M | 13.17M | 69.60M | 67.76M | 68.76M |
Change in Net Operating Assets | -23.86M | -31.22M | -31.43M | -25.12M | -18.63M |
Cash from Operations | -80.52M | -85.23M | -88.56M | -97.76M | -103.11M |
Capital Expenditure | -1.17M | -729.00K | -2.40M | -6.60M | -7.12M |
Sale of Property, Plant, and Equipment | 326.00K | 226.00K | 196.00K | 149.00K | 104.00K |
Cash Acquisitions | -- | -- | -- | -- | -- |
Divestitures | -- | -- | -- | -- | -- |
Other Investing Activities | 101.75M | 98.54M | 96.73M | 28.79M | -9.94M |
Cash from Investing | 100.90M | 98.04M | 94.53M | 22.33M | -16.96M |
Total Debt Issued | -- | -- | -- | -- | -- |
Total Debt Repaid | -- | -- | -- | -- | -- |
Issuance of Common Stock | 252.00K | 436.00K | 436.00K | 457.00K | 444.00K |
Repurchase of Common Stock | -38.00K | -68.00K | -186.00K | -289.00K | -404.00K |
Issuance of Preferred Stock | -- | -- | -- | -- | -- |
Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
Total Dividends Paid | -- | -- | -- | -- | -- |
Other Financing Activities | -- | -- | -- | 15.00K | 15.00K |
Cash from Financing | 214.00K | 368.00K | 250.00K | 183.00K | 55.00K |
Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
Net Change in Cash | 20.60M | 13.18M | 6.22M | -75.24M | -120.01M |